1. Background {#sec1}
=============

Malaria continues to remain an important cause of illness and death in countries in which it is endemic \[[@B1]\]. In 2016, there were an estimated 212 million cases of malaria globally and led to 445, 000 deaths, most of which were in African children under the age of 5. Irrespective of the effort made to minimize malaria incidence and prevalence globally, the burden of morbidity and mortality is high in African Region \[[@B2]\]. Despite a decreased malaria mortality rate in Ethiopia by \> 40% since 2010, high prevalence was observed in contrast to high household coverage of control interventions \[[@B2], [@B3]\].

The evolution of strains resistant to commonly used antimalarial drugs and the lack of inexpensive new drugs jeopardized the fight against malaria. This triggers the continuing need of research for novel antimalarial compounds \[[@B4], [@B5]\]. History has taught us how traditional medicines like*Artemisia annua* L. and bark of*Cinchona pubescens*Vahl are valuable in discovering new antimalarial drugs \[[@B6]--[@B8]\].

About 90% of the Ethiopian populations are dependent on traditional medicines for the management of diseases in both humans and animals \[[@B9]\]. The widespread use of traditional medicines in Ethiopia could be attributed to cultural acceptability, physical accessibility, and economic affordability as compared to modern medicine \[[@B10]\]. There are a number of plants utilized in Ethiopian ethnomedicine practice for the treatment of malaria. Studies conducted on several traditionally confirmed antimalarial activities of Ethiopian medicinal plants, such as*Calpurnia aurea*\[[@B11]\]*, Croton macrostachyus*\[[@B12]\],*Asparagus africanus*\[[@B13]\],*Withania somnifera*\[[@B14]\],*Dodonaea angustifolia* \[[@B15]\], and*Phytolacca dodecandra* \[[@B16]\].

*Gardenia ternifolia*Schumach. & Thonn. (Rubiaceae) is a shrub or small tree about 5 to 10 m high \[[@B17], [@B18]\]. In Ethiopia, stem and root barks of*G. ternifolia* are taken as a remedy for malaria \[[@B19], [@B20]\]. In addition, the plant is used medicinally by tribal healers to treat hemorrhoid lesions \[[@B21]\], gum bleeding \[[@B22]\], and stomachache \[[@B23]\] in human and ulcerative lymphangitis in livestock \[[@B24]\].

The leaves exudates of the plant showed*in vitro* antiplasmodial activity against*Plasmodium falciparum* \[[@B25]\]. Moreover, fruit extract of the plant possesses*in vitro* antiparasitic activity against*Theileria lestoquardi*that infects ruminant erythrocytes \[[@B26], [@B27]\]. Thus, based on the claims made by the traditional healers and*in vitro*antimalarial activity of the leaves surface exudates, the present study evaluated the*in vivo* antimalarial activity of 80% methanol extract and solvent fractions of the root barks of*G. ternifolia*.

2. Methods {#sec2}
==========

2.1. Plant Collection {#sec2.1}
---------------------

Root barks of*G. ternifolia*were collected in October, 2015, from its natural habitat around Mizan-Teferi, 581 km South West of Addis Ababa. The fresh root barks were wrapped with plastic sheets during transportation. The collected plant was identified as*G. ternifolia* by a taxonomist at the National Herbarium, College of Natural and Computational Sciences, Addis Ababa University, where a voucher specimen (no. DN 001) was deposited for a future reference.

2.2. Plant Extraction and Fractionation {#sec2.2}
---------------------------------------

Fresh root barks of the plant were thoroughly washed with distilled water to remove dirt and soil. The root bark samples were then air-dried under shade and pulverized into powder using sterile pestle and mortar. The powder (200 g) was cold macerated with 600 mL of 80% methanol in an Erlenmeyer flask for three consecutive days at room temperature. The same volume of solvent was used for successive extraction of the residues. The extraction process was facilitated using a mechanical shaker at 120 rpm. The extract (19% w/w) was transferred into vials and kept at −20°C until use.

The crude hydroalcoholic extract was subjected to fractionation using solvents with differing polarity (chloroform, n-butanol, and water). For fractionation purpose, crude extract was suspended in a separatory funnel using distilled water and the suspension was shaken with chloroform and n-butanol successively. All the fractions were kept in an amber glass bottle and stored in a refrigerator (−20°C). The percentage yield of butanol, chloroform, and aqueous fractions was 28.21%, 26.27%, and 45.52%, respectively.

2.3. Preliminary Phytochemical Screening {#sec2.3}
----------------------------------------

Both crude extract and solvent fractions were screened for the presence and absence of different phytochemical constituents to relate the secondary metabolites with antimalarial activity. Hence, tests for alkaloids, anthocyanins, flavonoids, glycosides, phenolic compounds, saponins, steroidal compounds, tannins, and terpenoids were carried out following standard procedures described by Debella (2002) \[[@B28]\] and Godgate and Rajaram (2013) \[[@B29]\].

2.4. Experimental Animals and Parasite {#sec2.4}
--------------------------------------

Healthy Swiss albino mice (22-31 g), aged 4-6 weeks, were purchased from Ethiopian Public Health Institute (EPHI). Mice were maintained in the laboratory under standard condition (temperature of 22 ± 3°C, relative humidity of 40-50% and 12 h light/12 h dark cycle) with a commercial food and water*ad libitum.* Mice were acclimatized for one week before the study. All procedures and techniques used in this study were in accordance with the guide for care and use of laboratory animals \[[@B30]\].

Chloroquine sensitive strain of*P. berghei* (ANKA ) was obtained from EPHI. The parasites were maintained by serial passage of blood from infected mice to noninfected ones on weekly basis.

2.5. Acute Toxicity Study {#sec2.5}
-------------------------

Noninfected female Swiss albino mice, fasted overnight, were used for the acute toxicity study. Following the period of fasting, the animals were weighed and 2000 mg/kg of the crude extract was administered by oral gavage. Food was then withheld for further 1 to 2 h. First, one female mouse was dosed and the mouse was observed continuously for the first 30 min and intermittently for 4 h, over a period of 24 h. Since no death was observed, another four female mice were dosed and gross behavioral changes like loss of appetite, hair erection, lacrimation, tremors, convulsions, mortality and other signs of toxic manifestation were observed for 14 days after administration of the extract \[[@B31]\].

2.6. *In Vivo* Antimalarial Screening {#sec2.6}
-------------------------------------

### 2.6.1. Parasite Inoculation {#sec2.6.1}

Albino mice previously infected with*P. berghei* having different levels of parasitemia (30-37%) were used as donors \[[@B32]\]. Donor mice were placed in closed chamber and euthanized with inhalation of anesthesia gas and infected blood was collected by cardiac puncture into heparinized vacutainer tube containing 0.5% trisodium citrate. The blood was then diluted in normal saline (0.9%) based on parasitemia level of the donor mice and the red blood cell (RBC) count of normal mice so that the final suspension would contain about 1×10^7^ parasitized red blood cells (PRBCs) in every 0.2 mL suspension \[[@B33]\]. Each mouse used in the study was infected intraperitoneally with 0.2 mL infected blood containing about 1×10^7^*P. berghei* parasitized RBCs.

### 2.6.2. Grouping and Dosing of Animals {#sec2.6.2}

To evaluate the antimalarial activity of crude extract and solvent fractions, infected mice were randomly divided into five groups of 6 mice each. For each test, three groups (I-III) were treated with the crude extract or solvent fractions at 200 mg/kg, 400 mg/kg, and 600 mg/kg, respectively. The remaining two groups served as positive and negative controls and received chloroquine 25 mg/kg (CQ25) and 10 mL/kg of vehicle, respectively. Each dose was reconstituted by distilled water and administered orally. Duration of administration depended on the type of test performed.

### 2.6.3. The 4-Day Suppressive Test {#sec2.6.3}

Evaluation of schizonticidal activity of the root barks of*G. ternifolia* crude extract and solvent fractions on early infection was carried out according to the method described by Peter et al. \[[@B34]\]. Treatment was started on the first day (D0) and 2 h postinfection and continued daily for 4 days (D1-D3). On the 5^th^ day (D4), blood was collected from the tail of each mouse using clean, nongreasy slides and thin films were made accordingly to determine parasitemia and percentage inhibition. In addition, each mouse was observed daily for determination of survival time.

### 2.6.4. Rane\'s (Curative) Test {#sec2.6.4}

Method described by Ryley and Peters \[[@B35]\] was employed to evaluate the curative potential of the plant. Thirty male mice were intraperitoneally inoculated with standard inoculums of 1×10^7^*P. berghei* PRBCs on the first day (Day 0). Seventy-two hours later, animals were randomly divided into 5 groups and dosed accordingly. Treatment continued once daily until the 7^th^ day (D3-D6). Geimsa stained thin blood film was prepared from the tail of each mouse daily for 5 days to monitor parasitemia level. Survival time was determined over a period of 30 days (D0-D29).

### 2.6.5. Prophylactic Test {#sec2.6.5}

The prophylactic activity of the extract was tested using the residual infection procedure described by Peters \[[@B36]\]. Adult male mice were weighed, randomized into five groups (n=6), and treated for four consecutive days. On the 5^th^ day (D4), all mice were infected with the*Plasmodium*. Seventy-two hour postinfection, parasitemia level, weight change, temperature, and packed cell volume (PCV) were determined. Then after, the mice were followed for 28 days for their survival to calculate mean survival time.

### 2.6.6. Packed Cell Volume Measurement {#sec2.6.6}

To determine the effectiveness of the extract and fractions in preventing the hemolytic effect of the parasite, PCV was measured \[[@B14]\]. Heparinized capillary tubes were used for the collection of blood from tail of the mice. The capillary tubes were filled to 3/4^th^ of their height with blood and sealed with sealing clay at their dry end. The tubes were then placed on a microhematocrit centrifuge (Centurion Scientific, UK) with the sealed end facing the periphery and centrifuged at 11,000 rpm for 5 min. Finally, the tubes were taken out of the centrifuge and PCV was determined using the standard hematocrit reader (Hawksley and Sons, England) \[[@B37]\]. PCV was calculated using the relation shown below \[[@B14]\]: $$\begin{matrix}
{\operatorname{}PCV} \\
{= \frac{\text{Volume  of  erythrocytes  in  agiven  volume  of  blood}}{\text{Total  blood  volume  examined}}} \\
{\mspace{2060mu} \times 100} \\
\end{matrix}$$

### 2.6.7. Parasitemia Measurement {#sec2.6.7}

The percentage parasitemia was obtained by counting the number of infected RBC out of the total RBC in random microscopic fields. Two stained slides for each mouse were examined \[[@B12]\]. Six different fields on each slide were counted to determine percentage parasitemia using the following formula \[[@B38]\]:$$\begin{matrix}
{\%\,\, parasitemia = \frac{\text{Number  of  PRBC}}{\text{Total  number  of  RBC}} \times 100} \\
\end{matrix}$$Percent parasitemia suppression of the extract and fractions was compared with respect to the controls. Percent parasitemia suppression was calculated using the following formula \[[@B38]\]: $$\begin{matrix}
{\text{Average  \%  of  Parasitemia  Suppression} = \frac{\text{Parasitemia  in  negative  control} - \text{Parasitemia  in  treatment  group}}{\text{Parasitemia  in  negative  control}} \times 100} \\
\end{matrix}$$

2.7. Data Analysis {#sec2.7}
------------------

Data were organized, edited, and analyzed using SPSS Version 20. Data obtained from all tests were analyzed with one-way ANOVA followed by Tukey*post hoc* test to compare the levels of parasitemia, survival time, and changes in body weight, PCV, and rectal temperature of the*P. berghei*infected mice between control and treatment groups. Results were deemed statistically significant if P values \< 0.05 at 95% confidence intervals.

3. Results {#sec3}
==========

3.1. Acute Toxicity Study {#sec3.1}
-------------------------

The acute toxicity study indicated that the extract caused no mortality at dose of 2000 mg/kg. Physical and behavioral observations of the experimental mice also revealed no visible signs of overt toxicity. This suggests that LD~50~ of the extract is greater than 2000 mg/kg.

3.2. Four-Day Suppressive Test {#sec3.2}
------------------------------

### 3.2.1. Chemosuppressive Effect of the Plant in the Suppressive Test {#sec3.2.1}

The 4-day suppressive study revealed that the extract as well as fractions exhibited a significant reduction of parasitemia (p\<0.001) compared to the negative control ([Table 1](#tab1){ref-type="table"}). The 600 mg/Kg dose of butanol fraction produced higher parasitemia suppression (51.33%) compared to the same dose of chloroform fraction (40.73%). Of the fractions, aqueous fraction exhibited the lowest chemosuppression against*P. berghei*. Moreover, the mean survival time of mice treated with the crude extract and fractions was increased in a dose-dependent manner ([Table 1](#tab1){ref-type="table"}). The standard drug markedly (p\<0.001) reduced parasite count to undetectable level and prolonged survival time of infected mice.

### 3.2.2. Effect on Body Weight and Rectal Temperature in Suppressive Test {#sec3.2.2}

The crude extract appeared to significantly avert loss of weight associated with infection as compared to negative control. As indicated in [Table 2](#tab2){ref-type="table"}, all the three doses of the crude extract were able to significantly (p\<0.05 for lower, p\<0.001 for middle and highest doses) prevent the decrease in rectal temperature caused by*P. berghei*infection compared to negative control.

### 3.2.3. Effect on Packed Cell Volume in Suppressive Test {#sec3.2.3}

Although the effects were lower than CQ25, crude extract (200 and 400 mg/kg), butanol fraction (200 and 400 mg/kg), and chloroform fraction (600 mg/Kg) treated groups significantly prevented reduction of PCV (p\<0.001) compared to the vehicle treated group ([Table 3](#tab3){ref-type="table"}).

3.3. Rane\'s Test {#sec3.3}
-----------------

### 3.3.1. Curative Effect of the Plant in Rane\'s Test {#sec3.3.1}

The crude extract at 400 and 600 mg/kg doses revealed a significant (p\<0.001) curative effect compared to vehicle treated group ([Table 4](#tab4){ref-type="table"}). Survival period was altered significantly by the lower (p\<0.01), middle (p\<0.001), and highest (p\<0.001) doses of test sample relative to negative control. However, the curative effect achieved with the extract was lower compared to CQ25.

### 3.3.2. Effect of Crude Extract on Body Weight and Rectal Temperature in Rane\'s Test {#sec3.3.2}

The crude extract exhibited a dose-dependent prevention of body weight reduction in infected mice ([Table 5](#tab5){ref-type="table"}). Moreover, CQ25 and all dose levels of the crude extract significantly (p\<0.001) prevented the reduction in rectal temperature compared to the negative control group.

### 3.3.3. Effect of Crude Extract on Packed Cell Volume in Rane\'s Test {#sec3.3.3}

The crude extract was able to significantly (p\<0.001) prevent PCV reduction compared to vehicle treated group ([Figure 1](#fig1){ref-type="fig"}).

3.4. Prophylactic Effect of the Plant {#sec3.4}
-------------------------------------

All doses of the crude extract and CQ25 significantly (p\<0.001) suppressed parasite load compared to negative control ([Table 6](#tab6){ref-type="table"}). Although complete eradication was not achieved, maximum suppression (84.83%; p\<0.001) of parasitemia was noted by the positive control. Survival time of the infected mice pretreated with the crude extract indicated that only the highest dose was capable of significantly (p\<0.01) prolonging survival time compared to control ([Table 6](#tab6){ref-type="table"}).

### 3.4.1. Effect of Crude Extract on Body Weight and Rectal Temperature in Prophylactic Test {#sec3.4.1}

CQ25 and highest dose of extract showed a significant (p\<0.001 for CQ25 and p\<0.01 for crude extract) protective effect in body weight reduction compared to vehicle treated group ([Table 7](#tab7){ref-type="table"}). Chloroquine treated group considerably prevented weight reduction in comparison to the middle (p\<0.01) and lower (p\<0.001) doses of crude extract. However, the highest dose of the crude extract appreciably (p\<0.001) prevented rectal temperature reduction compared to control mice.

### 3.4.2. Effect of Crude Extract on Packed Cell Volume in Prophylactic Test {#sec3.4.2}

Multiple comparison among PCV reductions ([Figure 2](#fig2){ref-type="fig"}) indicated that the highest dose (p\<0.001) and middle dose (p\<0.01) of crude extract and the standard drug (p \<0.001) were able to significantly attenuate PCV reduction compared to the negative control.

3.5. Preliminary Phytochemical Screening {#sec3.5}
----------------------------------------

Phytochemical screening revealed the presence of tannins, alkaloids, anthocyanins, terpenoids, saponins, phenols, steroids, and flavonoids in crude extract of*G. ternifolia* root barks. Of all the fractions, butanol fraction exhibited a maximal number of secondary metabolites ([Table 8](#tab8){ref-type="table"}).

4. Discussion {#sec4}
=============

Death or signs of toxicity was not observed in oral acute toxicity evaluation of the test extract and this could explain the safe folkloric use of the plant.*In vivo* model was opted for this study because it takes into account any prodrug effect and the likelihood of immune system in controlling infection as compared to*in vitro* study \[[@B33]\].

In the 4-day suppressive test, parasite suppression exhibited by the extract was comparable with other study done on*Aloe debrana*\[[@B32]\]. Moreover, the crude extract prolonged survival time in early parasite infection, which is concordant with study conducted on ethanolic leaf extract of*Chromolaena odorata* \[[@B39]\].

Among the fractions, butanol and chloroform fractions exerted a better chemosuppressive effect than aqueous fraction, suggesting the possible localization of active ingredients in these two fractions. This finding is in accordance with other studies in which butanol fraction exhibited a superior antimalarial activity \[[@B40], [@B41]\]. This effect could be attributed to the existence of alkaloids, flavonoids, saponins, and terpenoids in butanol fraction. On the other hand, aqueous fraction produced the lowest inhibition of parasitemia in the 4-day suppressive test. This could probably emanate from the absence of most of the bioactive secondary metabolites from this fraction. The finding is in line with other studies in which the antimalarial effect of aqueous fraction is less than chloroform and butanol fractions \[[@B12]\].

The chemosuppressive effect of the plant is similar to other species of the same genus such as*Gardenia sokotensis* \[[@B42]\] and*Gardenia Lutea* \[[@B43]\]. Previous study also conveyed that flavonoids and steroids isolated from*G. ternifolia* leaf surface exudates showed an*in vitro* antiplasmodial activity (IC~50~ values 1.06 and 0.94 *μ*g/mL) against*falciparum* strains \[[@B25]\].

Body weight loss, reduction in PCV, and low body temperature are cardinal signs of malaria-infected mice \[[@B44]\]. Hence, ideal plant extracts with antimalarial activity are expected to prevent malaria-associated reduction of body weight, PCV, and temperature due to the rise in parasitemia.

The highest doses of butanol and chloroform fractions showed a remarkable increment in body weight compared to the infected but untreated mice. This activity might have been resulted from the overall improvement in PCV, rectal temperature, and parasite clearance among treated mice \[[@B45]\]. However, aqueous fraction did not prevent weight reduction. This finding is in agreement with previous studies on aqueous fraction of other plants \[[@B46], [@B47]\].

A decrease in the metabolic rate of*P. berghei* infected mice occurs before death and is accompanied by a corresponding decrease in body temperature \[[@B15]\]. Active compound(s) should prevent the rapid dropping of rectal temperature. In 4-day suppressive test, all doses of the crude extract and middle and larger doses of butanol and chloroform fractions protected the decrease in rectal temperature associated with infection. Overall, this activity might probably indicate the ability of plant to ameliorate some pathological processes of malaria that cause reduction in body temperature \[[@B15]\].

In the chemosuppressive study, the extract and fractions of*G. ternifolia* significantly prevented PCV reduction in a dose-dependent manner. This effect is in line with the RBC protection effect of crude extract of*Clerodendrum myricoides* leaves,*Dodonaea angustifolia* seeds \[[@B32], [@B46]\], and*Croton macrostachyus* leaves \[[@B12]\].

In established infection, the crude extract exerted significant suppression of parasitemia. As indicated in the results section, all treated groups brought about reduction of parasitemia after the second dose; however, the standard drug started its activity right after the first dose. This delay of activity may be indicative of the need for a loading dose or the extract might have a slower onset of action compared to chloroquine. Since it is desirable to have both suppressive and curative activities in a phytodrug, it may be possible to consider this plant as a potential source of antimalarial agents \[[@B48]\].

The chemosuppresive effect of extract on established infection was higher than the 4-day suppressive test. This pronounced antimalarial activity observed in the established infection test may be due to inhibitory effect of the extract on generation of free radicals and hemolytic principles resulting from high parasitaemia level \[[@B49], [@B50]\]. This is further supported by the*in vitro* analysis in which flavonoid aglycones from the leaves of*G. ternifolia* exhibiting antioxidant activity that can counteract the oxidative damage induced by the malaria parasite \[[@B19]\].

To be active, the sample should suppress percent parasitemia by ≥ 30% \[[@B51]\]. Based on this assertion, the crude extract, butanol, and chloroform fractions are active against malaria infection.

5. Conclusion {#sec5}
=============

The present study indicated that crude extract and solvent fractions of*G. ternifolia*possess a promising antimalarial activity, with higher effect exhibited by the crude extract. The antimalarial action of the extract and solvent fractions has been attributed to the presence of semipolar to nonpolar ingredients in the root barks of the plant. Therefore, the extracts and solvent fractions of*G. ternifolia* could potentially be used as a new source for the development of new plant-based antimalarial agent.
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![Comparison of packed cell volume in malaria-infected mice treated with crude extract, chloroquine and placebo in the Rane\'s test. Data are expressed as mean ± SEM (n=6); a, compared to negative control; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control; CQ, chloroquine (positive control); GT, crude extract.](ECAM2018-9217835.001){#fig1}

![Results on packed cell volume of*Plasmodium berghei* infected mice treated with the 80% methanolic extract of*Gardenia ternifolia* root barks in the prophylactic test. Data are expressed as mean ± SEM (n=6); a, compared to CON; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001, D~0~ = preinoculated value on day three, D~7~ = postinoculated value on day seven.](ECAM2018-9217835.002){#fig2}

###### 

Antimalarial activity of 80% methanol extract and solvent fractions of *Gardenia ternifolia* root barks against *Plasmodium berghei* in 4-day suppressive test.

  Group   \% Parasitemia   \% Suppression    Survival Time
  ------- ---------------- ----------------- ---------------------
  CON     53.95±0. 71      0.00              6.33±0.21
  GT200   36.38±0.83       32.58^a3b3d3e3^   8.50±0.43^a2b3d3e3^
  GT400   28.58±0.65       47.02^a3b3e3^     11.17±0.31^a3b3e3^
  GT600   21.98±0.72       59.25^a3b3^       13.50±0.43^a3b3^
  CQ25    0.00±0.00        100.00^a3^        28.00±0.00^a3^
                                             
  CON     48.64±0.94       0.00              6.50±0.22
  BF200   33.61±0.90       30.89^a3b3d3e3^   8.83±0.60^a1b3e3^
  BF400   27.93±0.51       42.45^a3b3e3^     10.50±0.56^a3b3e1^
  BF600   23.68±0.59       51.33^a3b3^       12.83±0.60^a3b3^
  CQ25    0.00±0.00        100.00^a3^        28.00±0.00^a3^
                                             
  CON     50.49±0.60       0.00              6.33±0.21
  CF200   38.12±0.68       24.51^a3b3d3e3^   7.17±0.31^b3e3^
  CF400   34.77±0.63       31.13^a3b3e3^     8.00±0.45^a1b3e2^
  CF600   29.93±0.35       40.73^a3b3^       10.00±0.45^a3b3^
  CQ25    0.00±0.00        100.00^a3^        28.00±0.00^a3^
                                             
  CON     46.86±1.20       0.00              6.67±0.33
  AF200   39.99±1.19       14.67^a3b3e3^     7.00±0.37^b3^
  AF400   37.92±0.57       19.09^a3b3e1^     7.50±0.22^b3^
  AF600   34.80±0.68       25.75^a3b3^       7.83±0.40^b3^
  CQ25    0.00±0.00        100.00^a3^        28.00±0.00^a3^

Data are expressed as mean ± SEM (n=6); a, compared to CON; b, to CQ 25; c, to 200 mg/kg; d, to 400 mg/kg; e, 600 mg/kg: ^1^p\<0.05, ^2^p\<0.01, ^3^p\<0.001; CON, negative control, received distilled water 10 ml/kg; GT = crude extract of *Gardenia ternifolia*, BF = n-butanol fraction, CF = chloroform fraction, AF = aqueous fraction, and CQ = chloroquine; numbers (25,200,400,600) refer to dose in mg/kg.

###### 

Body weight and rectal temperature change of infected mice treated with crude extract and solvent fractions of *Gardenia ternifolia* root barks in 4-day suppressive test.

  Group   Weight (gram)   Temperature (^0^c)                                             
  ------- --------------- -------------------- --------------- ------------ ------------ ---------------
  CON     25.76±1.17      21.65±0.94           -13.55          35.85±0.38   33.15±0.33   -7.51
  GT200   26.78±1.34      24.73±1.41           -7.80^a1b3e1^   36.65±0.28   35.10±0.15   -4.21^a1b3e2^
  GT400   27.37±1.01      26.37±1.16           -3.67^a2b3^     36.50±0.25   35.58±0.17   -2.50^a3b2^
  GT600   28.51±0.56      28.46±0.81           -0.20^a3b2^     36.60±0.23   36.30±0.48   -0.81^a3^
  CQ25    28.02±1.11      30.95±1.10           10.55^a3^       36.32±0.34   36.82±0.25   1.40^a3^
                                                                                         
  CON     27.78±0.49      24.04±0.53           -11.14          36.75±0.31   34.25±0.26   -6.80
  BF200   28.91±0.48      26.81±0.42           -7.25^b3e1^     37.35±0.21   35.53±0.16   -4.85^b3e1^
  BF400   29.24±0.31      28.09±0.24           -3.91^a2b3^     37.45±0.21   36.02±0.30   -3.83^a2b3^
  BF600   27.93±0.48      27.77±0.60           -0.61^a3b3^     36.90±0.24   36.00±0.33   -2.45^a3b3^
  CQ25    27.07±0.70      30.23±0.99           11.60^a3^       36.80±0.43   37.45±0.21   1.80^a3^
                                                                                         
  CON     26.33±1.15      22.44±0.97           -12.20          36.30±0.53   33.55±0.33   -7.54
  CF200   26.85±0.98      24.15±1.24           -10.29^b3^      36.53±0.40   34.30±0.48   -6.12^b3^
  CF400   27.60±0.62      25.43±0.67           -7.91^b3^       36.70±0.33   35.05±0.43   -4.51^a1b3^
  CF600   28.41±0.63      27.20±0.60           -4.27^a3b3^     36.80±0.41   35.55±0.40   -3.39^a2b3^
  CQ25    28.10±0.82      31.39±0.76           11.83^a3^       36.70±0.40   37.28±0.26   1.65^a3^
                                                                                         
  CON     26.93±0.73      23.65±0.90           -10.72          36.45±0.25   33.10±0.50   -9.21
  AF200   27.74±0.85      25.04±0.91           -9.82^b3^       36.90±0.31   33.80±0.34   -8.41^b3^
  AF400   26.92±0.79      24.60±0.76           -8.61^b3^       36.35±0.36   33.70±0.34   -7.29^b3^
  AF600   28.61±0.61      26.34±0.65           -7.96^b3^       37.08±0.40   34.52±0.43   -6.92^b3^
  CQ25    28.32±0.63      31.21±0.68           10.22^a3^       37.00±0.35   37.90±0.23   2.45^a3^

Data are expressed as mean ± SEM (n=6); a, compared to CON; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control; GT = crude extract, BF = n-butanol fraction, CF = chloroform fraction, AF = aqueous fraction, and CQ = chloroquine; D~0~ = pretreatment value on day zero, D~4~ = posttreatment value on day four; numbers (25,200,400,600) refer to dose in mg/kg.

###### 

Effects of crude extract and fractions of *Gardenia ternifolia* root barks on packed cell volume of infected mice in 4-day suppressive test.

  Group   Packed Cell Volume                
  ------- -------------------- ------------ ---------------
  CON     59.91±2.51           55.11±2.48   -7.99
  GT200   64.86±1.79           62.57±1.90   -3.56^a2b3e1^
  GT400   61.98±2.40           61.22±2.63   -1.27^a3b2^
  GT600   56.96±1.43           57.00±1.40   0.09^a3b1^
  CQ25    59.77±1.75           62.19±1.89   4.05^a3^
                                            
  CON     63.68±2.72           59.11±2.73   -7.23
  BF200   63.10±1.16           60.58±1.07   -3.97^a1b3e2^
  BF400   61.09±1.95           60.11±1.99   -1.58^a3b3^
  BF600   64.02±2.96           63.91±2.94   -0.17^a3b3^
  CQ25    65.21±1.68           68.23±1.72   4.64^a3^
                                            
  CON     65.15±1.91           60.26±1.81   -7.51
  CF200   62.11±1.44           58.05±1.02   -6.47^b3e3^
  CF400   58.97±1.52           56.62±1.47   -3.97^a2b3^
  CF600   62.13±1.67           60.95±1.77   -1.93^a3b3^
  CQ25    59.82±1.74           62.57±2.15   4.52^a3^
                                            
  CON     64.14±3.90           59.55±3.78   -7.22
  AF200   62.66±2.50           58.41±2.29   -6.77^b3^
  AF400   64.71±2.30           60.86±2.07   -5.91^b3^
  AF600   58.71±1.29           55.50±1.25   -5.46^b3^
  CQ25    60.48±2.60           63.24±2.44   4.65^a3^

Data are expressed as mean ± SEM (n=6); a, compared to negative control; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control (received 10 ml/kg distilled water); CQ, chloroquine; GT, *G. ternifolia*; D~0~ = pretreatment value on day zero, D~4~ = posttreatment value on day four; numbers (25,200,400,600) refer to dose in mg/kg.

###### 

Antimalarial activity of the hydroalcoholic extract of *Gardenia ternifolia* root barks against *Plasmodium berghei* in Rane\'s test.

  Group   \% Parasitemia (D7)   \% Inhibition     Survival Time
  ------- --------------------- ----------------- ---------------------
  CON     38.12±0.75            0.00              7.17±0.17
  GT200   24.29±0.39            36.29^a3b3d3e3^   9.00±0.26^a2b3d3e3^
  GT400   18.26±0.61            52.11^a3b3e3^     11.50±0.43^a3b3e3^
  GT600   14.02±0.81            63.22^a3b3^       14.00±0.58^a3b3^
  CQ25    0.00±0.00             100.00^a3^        28.00±0.00^a3^

Data are expressed as mean ± SEM (n=6); a, compared to CON; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control (received 10 ml/kg distilled water); CQ, chloroquine; GT = crude extract of *G. ternifolia*. Numbers (25,200,400,600) refer to dose in mg/kg.

###### 

Body weight and rectal temperature of malaria infected mice before and after treatment with 80% methanolic extract of root barks of *Gardenia ternifolia* in Rane\'s test.

  Group     Weight (gram)   Temperature (^0^c)                                             
  --------- --------------- -------------------- --------------- ------------ ------------ ---------------
  Dose/kg   D~3~            D~7~                 \% Change       D~3~         D~7~         \% Change
  CON       25.64±1.20      22.19±1.15           -13.54          36.40±0.25   33.10±0.26   -9.05
  GT200     24.95±1.14      23.19±0.95           -6.90^a2b3e2^   35.90±0.22   34.45±0.20   -4.04^a3b3e3^
  GT400     25.56±1.07      24.82±1.22           -3.02^a3b3^     35.87±0.24   35.10±0.35   -2.14^a3b3^
  GT600     26.76±0.82      26.72±0.69           -0.09^a3b3^     36.00±0.23   35.75±0.25   -0.69^a3b2^
  CQ25      25.79±1.04      28.85±1.22           11.86^a3^       36.07±0.25   36.85±0.17   2.18^a3^

Data are expressed as mean ± SEM (n=6); a, compared to CON; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control; CQ, chloroquine (positive control); GT, Crude extract; D~3~ = pre-Rx value on day three, D~7~ = post-Rx value on day seven; numbers (25,200,400,600) refer to dose in mg/kg.

###### 

Parasitemia, percentage suppression and survival time of malaria infected mice treated with crude extract of *Gardenia ternifolia* root barks in repository test.

  Group   \% Parasitemia   \% Suppression   Survival Time
  ------- ---------------- ---------------- -----------------
  CON     21.49±0.70       0.00             6.67±0.21
  GT200   16.24±0.57       24.43^a3b3e3^    7.33±0.21^b3e1^
  GT400   15.25±0.49       29.04^a3b3e1^    8.50±0.84^b3^
  GT600   13.36±0.33       37.83^a3b3^      9.50±0.56^a2b3^
  CQ25    3.26±0.38        84.83^a3^        16.00±0.77^a3^

Data are expressed as mean ± SEM (n=6); a, compared to CON; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control; CQ, chloroquine (positive control); GT, crude extract.

###### 

Body weight and rectal temperature of *Plasmodium berghei* infected mice treated with crude extract of *Gardenia ternifolia* root barks in repository test.

  Group   Weight (gram)   Temperature (^0^c)                                         
  ------- --------------- -------------------- ----------- ------------ ------------ -------------
  CON     27.82±0.86      26.13±1.02           -6.19       36.90±0.36   34.98±0.45   -5.20
  GT200   27.68±0.93      26.28±0.86           -5.01^b3^   36.75±0.29   35.25±0.29   -4.08^b3e1^
  GT400   28.58±0.49      27.42±0.40           -4.02^b2^   37.20±0.22   35.98±0.27   -3.27^b2^
  GT600   28.55±0.76      27.88±0.80           -2.36^a2^   36.80±0.24   36.17±0.38   -1.73^a3^
  CQ25    28.54±0.64      28.63±0.76           0.28^a3^    37.00±0.31   36.85±0.36   -0.41^a3^

Data are expressed as mean ± SEM (n=6); a, compared to CON; b, compared to CQ 25 mg/kg; c, compared to 200 mg/kg; d, compared to 400 mg/kg; e, compared to 600 mg/kg; ^1^p\< 0.05; ^2^p\<0.01, ^3^p\<0.001; CON, negative control; CQ, chloroquine (positive control); GT, crude extract of *G. ternifolia*; D~0~ = preinoculated value on day three, D~7~ = postinoculated value on day seven; numbers (25,200,400,600) refer to dose in mg/kg.

###### 

Preliminary phytochemical screening of the hydroalcoholic extract and solvent fractions of *Gardenia ternifolia* root barks.

  Phytoconstituents   Crude Extract   Butanol Fraction   Chloroform Fraction   Aqueous Fraction
  ------------------- --------------- ------------------ --------------------- ------------------
  Alkaloids           \+              \+                 \+                    \-
  Anthocyanins        \+              \+                 \-                    \+
  Flavonoids          \+              \+                 \+                    \-
  Glycosides          \-              \-                 \-                    \-
  Phenols             \+              \+                 \-                    \-
  Saponins            \+              \+                 \+                    \+
  Steroids            \+              \+                 \+                    \-
  Tannins             \+              \+                 \+                    \-
  Terpenoids          \+              \-                 \+                    \-

-, absent; +, present.

[^1]: Academic Editor: Victor Kuete
